Preoperative serum anti-mullerian hormone level in women with ovarian endometrioma and mature cystic teratoma

Yonsei Medical Journal

Volumn 54, Issue 4, 2013, Pages 921-926

  Kim, Ju Yeong ^a   Jee, Byung Chul ^a,b,c   Suh, Chang Suk ^a,b,c   Kim, Seok Hyun ^b,c,d  

^a Seoul National University Bundang Hospital   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c Seoul National University   (South Korea)

^d Seoul National University Hospital   (South Korea)

Author keywords

Anti mullerian hormone; Endometrioma; Mature cystic teratoma; Ovarian reserve

Indexed keywords

MUELLERIAN INHIBITING FACTOR;

ADULT; AGE; ARTICLE; BODY MASS; CASE CONTROL STUDY; CONTROLLED STUDY; ECHOGRAPHY; ENDOMETRIOSIS; ENDOMETRIUM TUMOR; FEMALE; HORMONE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; OVARY TERATOMA; PREOPERATIVE EVALUATION; RETROSPECTIVE STUDY;

ANTI-MULLERIAN HORMONE; ENDOMETRIOMA; MATURE CYSTIC TERATOMA; OVARIAN RESERVE;

ADULT; ANTI-MULLERIAN HORMONE; BODY MASS INDEX; CASE-CONTROL STUDIES; ENDOMETRIOSIS; FEMALE; HUMANS; OVARIAN NEOPLASMS; OVARY; PREOPERATIVE PERIOD; RETROSPECTIVE STUDIES; TERATOMA;

EID: 84878255276     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2013.54.4.921     Document Type: Article

References (30)

1. Ozkan S, Murk W, Arici A. Endometriosis and infertility: epidemiology and evidence-based treatments. Ann N Y Acad Sci 2008;1127:92-100.
2. Verkauf BS. Incidence, symptoms, and signs of endometriosis in fertile and infertile women. J Fla Med Assoc 1987;74:671-5.
3. Navarro J, Garrido N, Remohí J, Pellicer A. How does endometriosis affect infertility? Obstet Gynecol Clin North Am 2003;30: 181-92.
4. Lessey BA. Implantation defects in infertile women with endometriosis. Ann N Y Acad Sci 2002;955:265-80.
5. Barnhart K, Dunsmoor-Su R, Coutifaris C. Effect of endometriosis on in vitro fertilization. Fertil Steril 2002;77:1148-55.
6. Wright VC, Chang J, Jeng G, Macaluso M; Centers for Disease Control and Prevention (CDC). Assisted reproductive technology surveillance--United States, 2005. MMWR Surveill Summ 2008; 57:1-23.
7. Kitajima M, Defrère S, Dolmans MM, Colette S, Squifflet J, Van Langendonckt A, et al. Endometriomas as a possible cause of reduced ovarian reserve in women with endometriosis. Fertil Steril 2011;96:685-91.
8. Shebl O, Ebner T, Sommergruber M, Sir A, Tews G. Anti muellerian hormone serum levels in women with endometriosis: a case-control study. Gynecol Endocrinol 2009;25:713-6.
9. Campos CS, Vaamonde D, Andreoli C, Martins AC, Genro VK, Souza CA, et al. Follicular-fluid anti-Müllerian hormone concentration is similar in patients with endometriosis compared with non-endometriotic patients. Reprod Biomed Online 2010;21:470-3.
10. Chang HJ, Han SH, Lee JR, Jee BC, Lee BI, Suh CS, et al. Impact of laparoscopic cystectomy on ovarian reserve: serial changes of serum anti-Müllerian hormone levels. Fertil Steril 2010;94:343-9.
11. Iwase A, Hirokawa W, Goto M, Takikawa S, Nagatomo Y, Nakahara T, et al. Serum anti-Müllerian hormone level is a useful marker for evaluating the impact of laparoscopic cystectomy on ovarian reserve. Fertil Steril 2010;94:2846-9.
12. Kitajima M, Khan KN, Hiraki K, Inoue T, Fujishita A, Masuzaki H. Changes in serum anti-Müllerian hormone levels may predict damage to residual normal ovarian tissue after laparoscopic surgery for women with ovarian endometrioma. Fertil Steril 2011;95: 2589-91. e1.
13. Kim MJ, Kim NY, Lee DY, Yoon BK, Choi D. Clinical characteristics of ovarian teratoma: age-focused retrospective analysis of 580 cases. Am J Obstet Gynecol 2011;205:32. e1-4.
14. Lakkis WG, Martin MC, Gelfand MM. Benign cystic teratoma of the ovary: a 6-year review. Can J Surg 1985;28:444-6.
15. Parazzini F, La Vecchia C, Negri E, Moroni S, Villa A. Risk factors for benign ovarian teratomas. Br J Cancer 1995;71:644-6.
16. Lee JY, Jee BC, Lee JR, Kim CH, Park T, Yeon BR, et al. Age-related distributions of anti-Müllerian hormone level and anti-Müllerian hormone models. Acta Obstet Gynecol Scand 2012;91:970-5.
17. de Vet A, Laven JS, de Jong FH, Themmen AP, Fauser BC. Antimüllerian hormone serum levels: a putative marker for ovarian aging. Fertil Steril 2002;77:357-62.
18. Kunt C, Ozaksit G, Keskin Kurt R, Cakir Gungor AN, Kanat-Pektas M, Kilic S, et al. Anti-Mullerian hormone is a better marker than inhibin B, follicle stimulating hormone, estradiol or antral follicle count in predicting the outcome of in vitro fertilization. Arch Gynecol Obstet 2011;283:1415-21.
19. Muttukrishna S, McGarrigle H, Wakim R, Khadum I, Ranieri DM, Serhal P. Antral follicle count, anti-mullerian hormone and inhibin B: predictors of ovarian response in assisted reproductive technology? BJOG 2005;112:1384-90.
20. Bungum L, Jacobsson AK, Rosén F, Becker C, Yding Andersen C, Güner N, et al. Circadian variation in concentration of anti-Müllerian hormone in regularly menstruating females: relation to age, gonadotrophin and sex steroid levels. Hum Reprod 2011;26:678-84.
21. La Marca A, Stabile G, Artenisio AC, Volpe A. Serum anti-Mullerian hormone throughout the human menstrual cycle. Hum Reprod 2006;21:3103-7.
22. Freeman EW, Gracia CR, Sammel MD, Lin H, Lim LC, Strauss JF 3rd. Association of anti-mullerian hormone levels with obesity in late reproductive-age women. Fertil Steril 2007;87:101-6.
23. Osuga Y, Koga K, Tsutsumi O, Yano T, Maruyama M, Kugu K, et al. Role of laparoscopy in the treatment of endometriosis-associated infertility. Gynecol Obstet Invest 2002;53 Suppl 1:33-9.
24. Arici A, Oral E, Bukulmez O, Duleba A, Olive DL, Jones EE. The effect of endometriosis on implantation: results from the Yale University in vitro fertilization and embryo transfer program. Fertil Steril 1996;65:603-7.
25. Azem F, Lessing JB, Geva E, Shahar A, Lerner-Geva L, Yovel I, et al. Patients with stages III and IV endometriosis have a poorer outcome of in vitro fertilization-embryo transfer than patients with tubal infertility. Fertil Steril 1999;72:1107-9.
26. Al-Azemi M, Bernal AL, Steele J, Gramsbergen I, Barlow D, Kennedy S. Ovarian response to repeated controlled stimulation in in-vitro fertilization cycles in patients with ovarian endometriosis. Hum Reprod 2000;15:72-5.
27. Díaz I, Navarro J, Blasco L, Simón C, Pellicer A, Remohí J. Impact of stage III-IV endometriosis on recipients of sibling oocytes: matched case-control study. Fertil Steril 2000;74:31-4.
28. Falconer H, Sundqvist J, Gemzell-Danielsson K, von Schoultz B, D'Hooghe TM, Fried G. IVF outcome in women with endometriosis in relation to tumour necrosis factor and anti-Müllerian hormone. Reprod Biomed Online 2009;18:582-8.
29. Halis G, Arici A. Endometriosis and inflammation in infertility. Ann N Y Acad Sci 2004;1034:300-15.
30. Lee KS, Joo BS, Na YJ, Yoon MS, Choi OH, Kim WW. Relationships between concentrations of tumor necrosis factor-alpha and nitric oxide in follicular fluid and oocyte quality. J Assist Reprod Genet 2000;17:222-8.